Wellcome Leap Issues New $50 Million 'Focused Antibiotics' Funding Scheme
The Wellcome Leap Program, established by Wellcome, aims to deliver breakthroughs in human health by providing funding at scale and within short timeframes. Wellcome Leap's fifteenth funding initiative is Focused Antibiotics, which aims to reformulate existing antibiotics to spare the gut microbiome without loss of treatment efficacy. Submission deadline: 15 May 2026 @ 11:59pm ET Abstract feedback sent: 30 May 2026 @ 7:00am ET Submission deadline: 29 June 2026 @ 11:59pm ET Proposal decision sent: 29 July 2026 @ 7:00am ET More information
